Story excerpt provided by Columbus Business First.
Written by Carrie Ghose.
Navidea Biopharmaceuticals Inc. is raising $2.5 million in a funding round led by the former principal of its largest institutional investor in a deal that places the valuation of its new disease-hunting subsidiary at $500 million.
Click here to read the complete article.
Originally published January 21, 2015.